| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Carolina Perez, Leon Morales-Quezada, Felipe Fregn. A combined therapeutic approach in stroke rehabilitation: A review on non-invasive brain stimulation plus pharmacotherapy. International journal of neurorehabilitation. vol 1. issue 3. 2020-09-29. PMID:28317024. |
the use of several drugs such as amphetamines, selective serotonin reuptake inhibitors (ssris), levodopa and cholinergic agents have been also proposed to enhance the motor function. |
2020-09-29 |
2023-08-13 |
Not clear |
| Talia Zeppelin, Lucy Kate Ladefoged, Steffen Sinning, Birgit Schiøt. Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies. Neuropharmacology. vol 161. 2020-07-14. PMID:30807752. |
we focus this review on the binding of cognate substrate and drugs belonging to the different families of antidepressants, including tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and multimodal drugs, as well as illicit drugs such as cocaine, amphetamines, and ibogaine. |
2020-07-14 |
2023-08-13 |
Not clear |
| Charlotte Martial, Héléna Cassol, Vanessa Charland-Verville, Carla Pallavicini, Camila Sanz, Federico Zamberlan, Rocío Martínez Vivot, Fire Erowid, Earth Erowid, Steven Laureys, Bruce Greyson, Enzo Tagliazucch. Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. Consciousness and cognition. vol 69. 2020-05-14. PMID:30711788. |
ketamine was followed by salvia divinorum (a plant containing a potent and selective κ receptor agonist) and a series of serotonergic psychedelics, including the endogenous serotonin 2a receptor agonist n,n-dimethyltryptamine (dmt). |
2020-05-14 |
2023-08-13 |
Not clear |
| Carla Pallavicini, Martina G Vilas, Mirta Villarreal, Federico Zamberlan, Suresh Muthukumaraswamy, David Nutt, Robin Carhart-Harris, Enzo Tagliazucch. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. NeuroImage. vol 200. 2020-03-20. PMID:31247301. |
classic serotonergic psychedelics are remarkable for their capacity to induce reversible alterations in consciousness of the self and the surroundings, mediated by agonism at serotonin 5-ht |
2020-03-20 |
2023-08-13 |
Not clear |
| Yiming Chen, Bruce E Blough, Kevin S Murnane, Clinton E Cana. The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT Drug testing and analysis. vol 11. issue 7. 2020-01-21. PMID:30845376. |
the synthetic cathinone psychostimulant α-ppp antagonizes serotonin 5-ht synthetic cathinones (scs) are β-keto analogs of amphetamines. |
2020-01-21 |
2023-08-13 |
human |
| Dino Luethi, Robert Widmer, Daniel Trachsel, Marius C Hoener, Matthias E Liecht. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives). European journal of pharmacology. vol 855. 2019-12-20. PMID:31063768. |
many ring-substituted phenethylamines exert psychedelic effects that are thought to be primarily mediated by interactions with serotonergic 5-hydroxytryptamine 2 (5-ht |
2019-12-20 |
2023-08-13 |
Not clear |
| Peter S Hasenhuetl, Shreyas Bhat, Felix P Mayer, Harald H Sitte, Michael Freissmuth, Walter Sandtne. A kinetic account for amphetamine-induced monoamine release. The Journal of general physiology. vol 150. issue 3. 2019-09-24. PMID:29439119. |
the plasmalemmal monoamine transporters for dopamine, norepinephrine, and serotonin (sert) are targets for amphetamines. |
2019-09-24 |
2023-08-13 |
Not clear |
| Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth, Henrik Grée. Fatal Poisonings Associated with New Psychoactive Substances. Handbook of experimental pharmacology. vol 252. 2019-06-13. PMID:30105471. |
the toxidromes commonly encountered after ingestion of cathinones and phenethylamines are of sympathomimetic and hallucinogenic character, which includes risk of developing a serotonin syndrome, excited delirium, and life-threatening cardiovascular effects. |
2019-06-13 |
2023-08-13 |
Not clear |
| Petra Strajhar, Patrick Vizeli, Melanie Patt, Patrick C Dolder, Denise V Kratschmar, Matthias E Liechti, Alex Odermat. Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study. The Journal of steroid biochemistry and molecular biology. vol 186. 2019-05-21. PMID:30381248. |
the effects of the amphetamines on glucocorticoid production were similar to those that were previously reported for methylphenidate (60 mg) but weaker than those for the serotonin releaser 3,4-methylenedioxymethamphetamine (mdma; 125 mg) or direct serotonin receptor agonist lysergic acid diethylamide (lsd; 0.2 mg). |
2019-05-21 |
2023-08-13 |
human |
| C de Baat, M C Verhoeff, P G M A Zweers, A Vissink, F Lobbezo. [Series: Medicaments and oral healthcare. Medicaments and addictive substances, potentially inducing or ameliorating bruxism]. Nederlands tijdschrift voor tandheelkunde. vol 126. issue 5. 2019-05-16. PMID:31081835. |
groups of medications known as having the potential adverse effect of bruxism are amphetamines, anticonvulsants and selective serotonin reuptake inhibitors. |
2019-05-16 |
2023-08-13 |
Not clear |
| José Carlos Bouso, Rafael G Dos Santos, Miguel Ángel Alcázar-Córcoles, Jaime E C Halla. Serotonergic psychedelics and personality: A systematic review of contemporary research. Neuroscience and biobehavioral reviews. vol 87. 2019-02-18. PMID:29452127. |
serotonergic psychedelics act as agonists at cortical 5-ht |
2019-02-18 |
2023-08-13 |
Not clear |
| Laura Hondebrink, Anne Zwartsen, Remco H S Westerin. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & therapeutics. vol 182. 2018-12-11. PMID:29097307. |
our effect fingerprints highlight the main modes of action for the different nps studied, including inhibition and/or reversal of monoamine reuptake transporters (cathinones and non-hallucinogenic phenethylamines), activation of 5-ht |
2018-12-11 |
2023-08-13 |
Not clear |
| Lohit Garg, Ghulam Akbar, Sahil Agrawal, Manyoo Agarwal, Leila Khaddour, Rishin Handa, Aakash Garg, Mahek Shah, Brijesh Patel, Bhavinkumar D Dala. Drug-induced pulmonary arterial hypertension: a review. Heart failure reviews. vol 22. issue 3. 2018-03-21. PMID:28417295. |
according to the current classification, pah can be associated with exposure to certain drugs or toxins such as anorectic agents, amphetamines, or selective serotonin reuptake inhibitors. |
2018-03-21 |
2023-08-13 |
Not clear |
| Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liecht. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 26. issue 8. 2018-01-23. PMID:27216487. |
several tryptamines, including psilocin, dmt, dipt, 4-oh-dipt, and 4-oh-met, interacted with the serotonin transporter and partially the norepinephrine transporter, similar to 3,4-methylenedioxymethamphetamine but in contrast to lsd and mescaline. |
2018-01-23 |
2023-08-13 |
human |
| Shreyas Bhat, Peter S Hasenhuetl, Ameya Kasture, Ali El-Kasaby, Michael H Baumann, Bruce E Blough, Sonja Sucic, Walter Sandtner, Michael Freissmut. Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates. The Journal of biological chemistry. vol 292. issue 40. 2017-10-11. PMID:28842491. |
the serotonin transporter (sert/slc6a4) has a rich pharmacology including inhibitors, releasers (amphetamines, which promote the exchange mode), and more recently, discovered partial substrates. |
2017-10-11 |
2023-08-13 |
Not clear |
| D E Nichols, M W Johnson, C D Nichol. Psychedelics as Medicines: An Emerging New Paradigm. Clinical pharmacology and therapeutics. vol 101. issue 2. 2017-05-29. PMID:28019026. |
scientific interest in serotonergic psychedelics (e.g., psilocybin and lsd; 5-ht |
2017-05-29 |
2023-08-13 |
Not clear |
| Teri M Furlong, Lee S Leavitt, Kristen A Keefe, Jong-Hyun So. Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats. Neurotoxicity research. vol 29. issue 4. 2016-12-27. PMID:26846719. |
the amphetamines also differentially damage dopamine (da) and serotonin (5-ht) systems, which regulate impulsive behavior; therefore, exposure to these drugs may differentially alter impulsive behavior to effect the progression of addiction. |
2016-12-27 |
2023-08-13 |
rat |
| Luca Raiteri, Maurizio Raiter. Multiple functions of neuronal plasma membrane neurotransmitter transporters. Progress in neurobiology. vol 134. 2016-08-25. PMID:26300320. |
some transporters reverse to release transmitters, like dopamine or serotonin, when activated by 'indirectly acting' substrates, like the amphetamines. |
2016-08-25 |
2023-08-13 |
Not clear |
| Nancy A Muma, Zhen M. Serotonylation and Transamidation of Other Monoamines. ACS chemical neuroscience. vol 6. issue 7. 2016-04-19. PMID:25615632. |
the availability of monoamines for monoaminylation is altered by antidepressants that target serotonin transporters, noradrenaline transporters, or the enzymatic degradation of monoamines as well as drugs of abuse such as cocaine and amphetamines. |
2016-04-19 |
2023-08-13 |
Not clear |
| Roberta Tittarelli, Giulio Mannocchi, Flaminia Pantano, Francesco Saverio Romol. Recreational use, analysis and toxicity of tryptamines. Current neuropharmacology. vol 13. issue 1. 2016-01-11. PMID:26074742. |
tryptamines include serotonin and melatonin as well as other compounds known for their hallucinogenic properties, such as psilocybin in 'magic mushrooms' and dimethyltryptamine (dmt) in ayahuasca brews. |
2016-01-11 |
2023-08-13 |
Not clear |